Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma

por Liu Y, Wu X, Gao Y, Zhang JG, Zhang DD, Gu SY, Zhu GH, Liu GL, Li XY
Publicado 2016

Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy

por Yu BF, Lu YF, Gao F, Jing P, Han W, Zhang PC, Liu GL, Ru N, Cui GH, Xu XH, Sun CL, Guan CJ, Che YB, Wu YL, Ma ZL, Fu Q, Liu J, Wang HY
Publicado 2015